BNCM | DELEX Merger

BNCM Announces the Expansion of DELEX PHARMA’s Medical Device Business

9th September 2024 BNCM announces today the expansion of DELEX PHARMAs medical device business through its strategic partnerships with leading international medical device companies in the US and Germany. These collaborations are expected to contribute around 30% of the companys total revenue, reinforcing DELEXs rapid growth in the healthcare sector.

BNCM Announces 11 New Products from DELEX PHARMA to Propel Growth

3rd September 2024, Quezon City, Philippines Delex Pharma International Inc. has launched an impressive array of 11 new pharmaceutical products in the first half of 2024, setting the stage for significant growth across multiple therapeutic areas. This launch reflects Delex Pharma’s commitment to addressing critical healthcare needs in the Philippines, particularly in the fields of critical care, oncology, anesthesia, and medical devices.